{
    "clinical_study": {
        "@rank": "166327", 
        "acronym": "PTL", 
        "arm_group": [
            {
                "arm_group_label": "12 hours Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "Those patient will be given 12 hours dexamethasone after randomization"
            }, 
            {
                "arm_group_label": "24 hours Dexamethasone", 
                "arm_group_type": "Experimental", 
                "description": "Those patient will be give 24 hours dexamethasone after randomization"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators sought to determine whether the incidence of neonatal respiratory distress\n      syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of\n      dexamethasone."
        }, 
        "brief_title": "Dexamethasone for Preterm Labour", 
        "completion_date": {
            "#text": "August 2012", 
            "@type": "Actual"
        }, 
        "condition": "Prematurity", 
        "condition_browse": {
            "mesh_term": "Obstetric Labor, Premature"
        }, 
        "detailed_description": {
            "textblock": "The administration of glucocorticoids to accelerate fetal lung maturity in patients with\n      preterm delivery plays an important role for obstetrics and neonatal care. Many studies have\n      shown that maternal administration of glucocorticoids has a significant beneficial effect in\n      decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at\n      28-34 weeks of gestation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patient with threatened or established preterm labor between 28 - 34 weeks\n             attended to our emergency unit\n\n        Exclusion Criteria:\n\n          -  emergent obstetric conditions like:\n\n               -  Antepartum hemorrhage in severe attack\n\n               -  Antepartum eclampsia"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01697098", 
            "org_study_id": "Dexa WHH"
        }, 
        "intervention": [
            {
                "arm_group_label": "24 hours Dexamethasone", 
                "intervention_name": "Dexamethasone 24 hours", 
                "intervention_type": "Drug", 
                "other_name": "glucocorticoids"
            }, 
            {
                "arm_group_label": "12 hours Dexamethasone", 
                "intervention_name": "Dexamethasone 12", 
                "intervention_type": "Drug", 
                "other_name": "glucocorticoids"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "Glucocorticoids", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dexamethasone", 
            "preterm labour", 
            "respiratory distress"
        ], 
        "lastchanged_date": "September 28, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Assiut", 
                    "country": "Egypt", 
                    "zip": "71111"
                }, 
                "name": "Women Health Hospital - Assiut university"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial", 
        "other_outcome": {
            "description": "Determine whether the incidence of admission to Neonatal intensive care  is similar with 12- vs 24-hour dosing interval of dexamethasone.", 
            "measure": "Neonatal intensive care", 
            "safety_issue": "No", 
            "time_frame": "6 month"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of dexamethasone.", 
            "measure": "respiratory distress syndrome (RDS)", 
            "safety_issue": "No", 
            "time_frame": "6 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01697098"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Assiut University", 
            "investigator_full_name": "Mohammed Khairy Ali", 
            "investigator_title": "Women Health Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Determine whether the incidence of perinatal mortality is similar with 12- vs 24-hour dosing interval of dexamethasone.", 
            "measure": "Perinatal mortality", 
            "safety_issue": "No", 
            "time_frame": "6 month"
        }, 
        "source": "Assiut University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assiut University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}